Paolo Amami - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Paolo Amami

Showing results (11-20 of 11) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 11 results.

BMJ Neurology Open|November 29, 2023

Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in <i>GBA</i>-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocolFabiana Colucci, Micol Avenali, Rosita De Micco, et al.

Pageof 2

Search research articles

Showing results (11-20 of 11) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 11 results.

BMJ Neurology Open|November 29, 2023

Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in <i>GBA</i>-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocolFabiana Colucci, Micol Avenali, Rosita De Micco, et al.

Pageof 2